Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century

Authors:

Abstract
The World Health Organization (WHO) defines rational drug prescribing as appropriate medicines in adapted doses for an adequate period of time.1 In Organisation for Economic Co-operation and Development (OECD) member countries,2 where drugs are reimbursed by health insurance schemes for large parts of the population, irrational drug prescribing may be frequent, especially for outpatient prescriptions.1,3,4 The pediatric population, notably the youngest children, should be prioritized for monitoring irrational outpatient drug use because of developmental immaturity and a lower level of evaluation of drugs compared with the adult population, despite the introduction of new regulations.5 Indeed, several severe rare or long-term adverse effects were found for drugs used at high rates in pediatrics.6-10 Furthermore, encounters between the pediatric population and potential prescribers are frequent in the first years of life because of numerous symptoms and self-limited diseases.11,12 Irrational prescribing may vary among countries by primary care physicians’ initial and continuous education,4 parental health literacy and attitudes toward drugs,3,13 drug regulatory authority policies,14 and health system characteristics.15 Because epidemiological patterns of the main pediatric diseases are similar in countries with advanced economies,16 comparing the prevalence of pediatric outpatient prescriptions (POPs) among these countries may reveal substantial discrepancies regarding inadequate practices at the national scale and may guide corrective actions.17

This publication has 70 references indexed in Scilit: